65 related articles for article (PubMed ID: 3986947)
1. The emergence of resistance and the therapy of septicaemia.
Phillips I; Shannon K
Chemioterapia; 1985 Feb; 4(1):90-4. PubMed ID: 3986947
[TBL] [Abstract][Full Text] [Related]
2. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of the plasmid-mediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriaceae from blood cultures in Liverpool, UK.
Corkill JE; Anson JJ; Hart CA
J Antimicrob Chemother; 2005 Dec; 56(6):1115-7. PubMed ID: 16260446
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
[TBL] [Abstract][Full Text] [Related]
6. Multiple antibiotic resistance in Klebsiella spp. and other Enterobacteriaceae isolated in Singapore.
Inglis TJ; Kumarasinghe G; Chow C; Liew HY
Singapore Med J; 1994 Dec; 35(6):602-4. PubMed ID: 7761885
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
Le Noc P; Bryskier A; Le Noc D
Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens.
Goldstein FW; Gutmann L; Williamson R; Collatz E; Acar JF
Ann Microbiol (Paris); 1983; 134A(3):329-37. PubMed ID: 6357025
[TBL] [Abstract][Full Text] [Related]
11. [Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins].
Nauciel C; Philippon A; Ronco E; Pilliot J; Guenounou M; Paul G; Brunel D; Outin HD
Presse Med; 1985 Mar; 14(12):673-6. PubMed ID: 3157961
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the presence of different broad-spectrum beta-lactamases among clinical isolates of Enterobacteriacae.
Nagy E; Pragai Z; Kóczián Z; Hajdú E; Fodor E
Acta Microbiol Immunol Hung; 1998; 45(3-4):433-46. PubMed ID: 9873949
[TBL] [Abstract][Full Text] [Related]
13. [Enterobacter cloacae. In vivo emergence of a variant resistant to new beta-lactams during treatment with lamoxactam-gentamicin].
Jarlier V; Philippon A; Nicolas MH; Bismuth R; Paul G; Fusciardi J
Pathol Biol (Paris); 1984 May; 32(5):399-403. PubMed ID: 6739148
[TBL] [Abstract][Full Text] [Related]
14. [beta-Lactam antibiotics--mechanisms of action and resistance in Enterobacteriaceae].
Lausová A; Bujdáková H; Kettner M
Epidemiol Mikrobiol Imunol; 1997 May; 46(2):73-80. PubMed ID: 9264797
[TBL] [Abstract][Full Text] [Related]
15. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological study of Enterobacter cloacae resistant to 3rd generation cephalosporins: a preliminary report.
Giamarellou H; Koratzanis G; Kanellakopoulou K; Daikos GK
Chemioterapia; 1985 Feb; 4(1):43-6. PubMed ID: 3986944
[TBL] [Abstract][Full Text] [Related]
17. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
[TBL] [Abstract][Full Text] [Related]
18. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
[TBL] [Abstract][Full Text] [Related]
19. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
[TBL] [Abstract][Full Text] [Related]
20. Spread of novel expanded-spectrum beta-lactamases in Enterobacteriaceae in a university hospital in the Paris area, France.
Lartigue MF; Fortineau N; Nordmann P
Clin Microbiol Infect; 2005 Jul; 11(7):588-91. PubMed ID: 15966981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
